When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges - SELLAS Life Sci

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly lucrative drug launch.